Schedule 13G ownership disclosure
Adagene Inc.
Ordinary shares, par value US$0.0001 per share · CUSIP: 005329107
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- WuXi PharmaTech Healthcare Fund I L.P.
Shares: 4,121,815.00 · Class: 7.0%
- WuXi AppTec Co., Ltd.
Shares: 4,121,815.00 · Class: 7.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001678057-25-000006
- Form type
- SCHEDULE 13G/A
- Filer
- Adagene Inc.
- CIK
- CIK 1818838
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership